Viewing StudyNCT02088541



Ignite Creation Date: 2024-05-06 @ 2:35 AM
Last Modification Date: 2024-10-26 @ 11:21 AM
Study NCT ID: NCT02088541
Status: COMPLETED
Last Update Posted: 2023-01-26
First Post: 2014-03-09

Brief Title: Selinexor KPT-330 in Older Patients With Relapsed AML
Sponsor: Karyopharm Therapeutics Inc
Organization: Karyopharm Therapeutics Inc

Conditions & Keywords Data

Conditions:
Name
Acute Myeloid Leukemia AML
Keywords:
Name View
Acute Myeloid Leukemia View
Karyopharm View
Selinexor View
KPT-330 View
RelapsedRefractory Acute Myeloid Leukemia View
AML View